BACKGROUND: Cluster headache (CH) patients often receive unsatisfactory treatment and may explore illicit substances as alternatives. We aimed to explore this use of illicit drugs for CH treatment. METHODS: We invited CH patients from an Internet-based self-help group to complete a questionnaire regarding their therapeutic use of illicit substances. RESULTS: Of the 54 respondents, 29 were classified as chronic and 39 were drug-resistant cases. Fifty patients had previously tried subcutaneous sumatriptan, 40 had tried O2, and 48 had tried at least one prophylactic treatment. All 54 patients specified that they were dissatisfied with conventional treatments. Thirty-four patients had used cannabinoids, 13 cocaine, 8 heroin, 18 psilocybin, 12 lysergic acid amide (LSA), and 4 lysergic acid diethylamide (LSD). DISCUSSION: Some patients with intractable CH decided to try illicit drugs concomitantly with cessation of medical care. Most of these patients found suggestions for illicit drug use on the Internet. Many patients seemed to underestimate the judicial consequences of, and had an overestimated confidence in the safety of, such illicit treatments. Physicians are often not informed by patients of their choice to use illicit drugs. This leads to questions regarding the true nature of the physician-patient relationship among dissatisfied CH patients.

The use of illicit drugs as self-medication in the treatment of cluster headache. Results from an Italian online survey / DI LORENZO, Cherubino; Coppola, Gianluca; Di Lorenzo, G; Bracaglia, Martina; Rossi, P; Pierelli, Francesco. - In: CEPHALALGIA. - ISSN 0333-1024. - ELETTRONICO. - 36:2(2016), pp. 194-198. [10.1177/0333102415583145]

The use of illicit drugs as self-medication in the treatment of cluster headache. Results from an Italian online survey

DI LORENZO, CHERUBINO;COPPOLA, GIANLUCA;BRACAGLIA, MARTINA;PIERELLI, Francesco
2016

Abstract

BACKGROUND: Cluster headache (CH) patients often receive unsatisfactory treatment and may explore illicit substances as alternatives. We aimed to explore this use of illicit drugs for CH treatment. METHODS: We invited CH patients from an Internet-based self-help group to complete a questionnaire regarding their therapeutic use of illicit substances. RESULTS: Of the 54 respondents, 29 were classified as chronic and 39 were drug-resistant cases. Fifty patients had previously tried subcutaneous sumatriptan, 40 had tried O2, and 48 had tried at least one prophylactic treatment. All 54 patients specified that they were dissatisfied with conventional treatments. Thirty-four patients had used cannabinoids, 13 cocaine, 8 heroin, 18 psilocybin, 12 lysergic acid amide (LSA), and 4 lysergic acid diethylamide (LSD). DISCUSSION: Some patients with intractable CH decided to try illicit drugs concomitantly with cessation of medical care. Most of these patients found suggestions for illicit drug use on the Internet. Many patients seemed to underestimate the judicial consequences of, and had an overestimated confidence in the safety of, such illicit treatments. Physicians are often not informed by patients of their choice to use illicit drugs. This leads to questions regarding the true nature of the physician-patient relationship among dissatisfied CH patients.
2016
cluster headache; LSA; LSD; illicit drugs; psilocybin
01 Pubblicazione su rivista::01a Articolo in rivista
The use of illicit drugs as self-medication in the treatment of cluster headache. Results from an Italian online survey / DI LORENZO, Cherubino; Coppola, Gianluca; Di Lorenzo, G; Bracaglia, Martina; Rossi, P; Pierelli, Francesco. - In: CEPHALALGIA. - ISSN 0333-1024. - ELETTRONICO. - 36:2(2016), pp. 194-198. [10.1177/0333102415583145]
File allegati a questo prodotto
File Dimensione Formato  
DiLorenzo_Use-illicit-drugs_2015.pdf

solo gestori archivio

Note: Di Lorenzo_Illicit
Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 130.93 kB
Formato Adobe PDF
130.93 kB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/845586
Citazioni
  • ???jsp.display-item.citation.pmc??? 6
  • Scopus 26
  • ???jsp.display-item.citation.isi??? 21
social impact